financetom
Business
financetom
/
Business
/
OpenAI allows employees to sell $1.5 bln stock to SoftBank, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI allows employees to sell $1.5 bln stock to SoftBank, sources say
Nov 27, 2024 12:00 AM

Nov 27 (Reuters) - ChatGPT-owner OpenAI is allowing its

employees to sell roughly $1.5 billion worth of shares in a new

tender offer to Japan's SoftBank Group, two sources

familiar with the matter told Reuters on Wednesday.

SoftBank's billionaire CEO Masayoshi Son has been

persistent in seeking a larger stake in the startup after

investing in the last funding round, according to CNBC, which

first reported the news.

The Microsoft ( MSFT )-backed artificial intelligence start-up

raised $500 million from the Japanese conglomerate, according to

a media report, in a $6.6 billion funding round in October at a

valuation of $157 billion.

OpenAI employees will have until Dec. 24 to decide if they

want to participate in the new funding round, a source told

Reuters, adding that the stock's offer price aligns with the

company's last funding round. The investment will come from

SoftBank's Vision Fund 2, another source said.

The sources declined to be named as they were not

authorized to speak to the media. SoftBank and OpenAI declined

to comment.

Son has been pushing to expand his conglomerate's exposure

to the AI wave, taking a stake in OpenAI and acquiring chip

startup Graphcore.

He recently said that he was saving up funds "so I can

make the next big move," but did not provide any details about

his investment plans.

OpenAI's meteoric rise in terms of product popularity and

valuation has captured the world's imagination. Since the launch

of ChatGPT, it has attracted 250 million weekly active users.

(Additional reporting by Shubham Kalia in Bengaluru; Editing by

Abinaya Vijayaraghavan)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PRESS DIGEST- Financial Times - March 5
PRESS DIGEST- Financial Times - March 5
Mar 4, 2024
March 5 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Cinven agrees to buy majority stake in fund administrator Alter Domus - Jeremy Hunt set to give motorists 5 bln pound tax break in the Budget - 'Erroneous' filings highlight flaws...
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Mar 4, 2024
05:31 PM EST, 03/04/2024 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) said Monday it plans a private placement of $250 million in principal amount of convertible notes due 2029. Initial purchasers will have the option to buy up to an additional $37.5 million principal amount of notes, according to the company. Net proceeds, along with cash at hand,...
BRIEF-Bowflex Inc Says Co Files For Voluntary Chapter 11 Protection & Reaches Stalking Horse Agreement To Facilitate Sale
BRIEF-Bowflex Inc Says Co Files For Voluntary Chapter 11 Protection & Reaches Stalking Horse Agreement To Facilitate Sale
Mar 4, 2024
March 5 (Reuters) - BowFlex Inc ( BFX ): * BOWFLEX INC. ( BFX ) FILES FOR VOLUNTARY CHAPTER 11 PROTECTION AND REACHES STALKING HORSE AGREEMENT TO FACILITATE SALE * BOWFLEX ( BFX ) - SECURED COMMITMENT FOR $25 MILLION IN DIP FINANCING TO CONTINUE TO FULFILL CUSTOMER ORDERS AND SUPPORT ORDINARY COURSE OPERATIONS * BOWFLEX ( BFX ) :...
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
Mar 4, 2024
March 4 (Reuters) - Telix Pharmaceuticals Ltd ( TLPPF ): * TELIX TO ACQUIRE ARTMS, INC. AND ITS ADVANCED ISOTOPE PRODUCTION PLATFORM * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO BE FINANCIALLY ACCRETIVE, ADD ADDITIONAL REVENUE * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO HAVE POSITIVE IMPACT ON GROSS MARGINS FOR ILLUCCIX...
Copyright 2023-2026 - www.financetom.com All Rights Reserved